Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting

V. Černý, M. Maegele, V. Agostini, D. Fries, SR. Leal-Noval, G. Nardai, G. Nardi, A. Östlund, H. Schöchl

. 2022 ; 48 (2) : 763-774. [pub] 20210105

Jazyk angličtina Země Německo

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22018957
E-zdroje Online Plný text

NLK ProQuest Central od 2007-02-01 do Před 1 rokem
CINAHL Plus with Full Text (EBSCOhost) od 2007-02-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest) od 2007-02-01 do Před 1 rokem
Health & Medicine (ProQuest) od 2007-02-01 do Před 1 rokem

PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex concentrates [PCCs] and fibrinogen concentrate [FCH]). Guidelines for TIC management vary across Europe and a clear definition of TIC is still lacking. METHODS: An advisory board involving European trauma experts was held on 02 February 2019, to discuss clinical experience in the management of trauma-related bleeding and recommendations from European guidelines, focusing on CFC use (mainly FCH). This review summarises the discussions, including TIC definitions, gaps in the guidelines that affect their implementation, and barriers to use of CFCs, with suggested solutions. RESULTS: A definition of TIC, which incorporates clinical (e.g. severe bleeding) and laboratory parameters (e.g. low fibrinogen) is suggested. TIC should be treated immediately with TXA and FCH/red blood cells; subsequently, if fibrinogen ≤ 1.5 g/L (or equivalent by viscoelastic testing), treatment with FCH, then PCC (if bleeding continues) is suggested. Fibrinogen concentrate, and not FFP, should be administered as first-line therapy for TIC. Several initiatives may improve TIC management, with improved medical education of major importance; generation of new and stronger data, simplified clinical practice guidance, and improved access to viscoelastic testing are also critical factors. CONCLUSIONS: Management of TIC is challenging. A standard definition of TIC, together with initiatives to facilitate effective CFC administration, may contribute to improved patient care and outcomes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018957
003      
CZ-PrNML
005      
20220804135220.0
007      
ta
008      
220720s2022 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s00068-020-01563-2 $2 doi
035    __
$a (PubMed)33399876
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Černý, Vladimir $u Department of Anesthesiology, Perioperative Medicine and Intensive Care, JE Purkinje University, Usti Nad Labem, Masaryk Hospital, Prague, Czech Republic. cernyvla1960@gmail.com
245    10
$a Variations and obstacles in the use of coagulation factor concentrates for major trauma bleeding across Europe: outcomes from a European expert meeting / $c V. Černý, M. Maegele, V. Agostini, D. Fries, SR. Leal-Noval, G. Nardai, G. Nardi, A. Östlund, H. Schöchl
520    9_
$a PURPOSE: Trauma is a leading cause of mortality, with major bleeding and trauma-induced coagulopathy (TIC) contributing to negative patient outcomes. Treatments for TIC include tranexamic acid (TXA), fresh frozen plasma (FFP), and coagulation factor concentrates (CFCs, e.g. prothrombin complex concentrates [PCCs] and fibrinogen concentrate [FCH]). Guidelines for TIC management vary across Europe and a clear definition of TIC is still lacking. METHODS: An advisory board involving European trauma experts was held on 02 February 2019, to discuss clinical experience in the management of trauma-related bleeding and recommendations from European guidelines, focusing on CFC use (mainly FCH). This review summarises the discussions, including TIC definitions, gaps in the guidelines that affect their implementation, and barriers to use of CFCs, with suggested solutions. RESULTS: A definition of TIC, which incorporates clinical (e.g. severe bleeding) and laboratory parameters (e.g. low fibrinogen) is suggested. TIC should be treated immediately with TXA and FCH/red blood cells; subsequently, if fibrinogen ≤ 1.5 g/L (or equivalent by viscoelastic testing), treatment with FCH, then PCC (if bleeding continues) is suggested. Fibrinogen concentrate, and not FFP, should be administered as first-line therapy for TIC. Several initiatives may improve TIC management, with improved medical education of major importance; generation of new and stronger data, simplified clinical practice guidance, and improved access to viscoelastic testing are also critical factors. CONCLUSIONS: Management of TIC is challenging. A standard definition of TIC, together with initiatives to facilitate effective CFC administration, may contribute to improved patient care and outcomes.
650    12
$a koagulopatie $x terapie $7 D001778
650    _2
$a koagulační faktory $x farmakologie $x terapeutické užití $7 D001779
650    _2
$a fibrinogen $x terapeutické užití $7 D005340
650    _2
$a krvácení $x farmakoterapie $x etiologie $7 D006470
650    12
$a hemostatika $x terapeutické užití $7 D006490
650    _2
$a lidé $7 D006801
650    12
$a kyselina tranexamová $x terapeutické užití $7 D014148
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Maegele, Marc $u Department of Trauma and Orthopedic Surgery, Institute for Research in Operative Medicine (IFOM), University Witten/Herdecke, Cologne-Merheim Medical Center (CMMC), Cologne, Germany
700    1_
$a Agostini, Vanessa $u IRCCS Ospedale Policlinico San Martino, Genova, Italy
700    1_
$a Fries, Dietmar $u Department for General and Surgical Critical Care Medicine, Medical University Innsbruck, Innsbruck, Austria
700    1_
$a Leal-Noval, Santiago R $u Critical Care Division, University Hospital 'Virgen del Rocio', Seville, Spain
700    1_
$a Nardai, Gábor $u Péterfy Sándor Str. Hospital and Trauma Center, Budapest, Hungary
700    1_
$a Nardi, Giuseppe $u Department of Anesthesia and Intensive Care, Rimini Hospital, Rimini, Italy
700    1_
$a Östlund, Anders $u Perioperative Medicine and Intensive Care, Karolinska University Hospital Solna, Stockholm, Sweden
700    1_
$a Schöchl, Herbert $u AUVA Trauma Centre Salzburg, Salzburg, Austria
773    0_
$w MED00157536 $t European journal of trauma and emergency surgery : official publication of the European Trauma Society $x 1863-9941 $g Roč. 48, č. 2 (2022), s. 763-774
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33399876 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804135214 $b ABA008
999    __
$a ok $b bmc $g 1822516 $s 1170200
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 48 $c 2 $d 763-774 $e 20210105 $i 1863-9941 $m European journal of trauma and emergency surgery $n Eur J Trauma Emerg Surg $x MED00157536
LZP    __
$a Pubmed-20220720

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...